menu
    • menu

    Company profile for Celyad

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celyad is a biopharmaceutical company, specialized in CAR-T cell therapy, that is developing landmark technologies aimed at treating severe diseases with poor prognosis such as cancer. Our scientific approach is inspired by the natural mechanisms that are used by the body to fight disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CelyadBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Axis Business Park Rue Edouard Belin 2 1435 Mont-Saint-Guibert
    Telephone
    Telephone
    +32(0) 10 39 41 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://celyad.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/celyad?trk=biz-companies-cym
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CelyadSA

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celyad receives approximately EUR 9.8m in private placement from shareholders
    Celyad receives approximately EUR 9.8m in private placement from shareholders

    24 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/24/2731567/0/en/Celyad-Oncology-receives-approximately-EUR-9-8m-in-private-placement-commitments-from-historical-shareholders.html

    GLOBENEWSWIRE
    24 Aug 2023
    Share Share
    Celyad Oncology announces receipt of Nasdaq delisting notice
    Celyad Oncology announces receipt of Nasdaq delisting notice

    15 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/15/2669268/0/en/Celyad-Oncology-announces-receipt-of-Nasdaq-delisting-notice.html

    GLOBENEWSWIRE
    15 May 2023
    Share Share
    Celyad announces receipt of Nasdaq initial notification on ADS bid price
    Celyad announces receipt of Nasdaq initial notification on ADS bid price

    24 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/24/2653299/0/en/Celyad-Oncology-announces-receipt-of-Nasdaq-initial-notification-on-ADS-bid-price.html

    GLOBENEWSWIRE
    24 Apr 2023
    Share Share
    Celyad Oncology announces receipt of Nasdaq notice
    Celyad Oncology announces receipt of Nasdaq notice

    04 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/04/2641197/0/en/Celyad-Oncology-announces-receipt-of-Nasdaq-notice.html

    GLOBENEWSWIRE
    04 Apr 2023
    Share Share
    Celyad Oncology appoints Georges Rawadi as its new CEO
    Celyad Oncology appoints Georges Rawadi as its new CEO

    24 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/24/2633752/0/en/Celyad-Oncology-appoints-Georges-Rawadi-as-its-new-CEO.html

    GLOBENEWSWIRE
    24 Mar 2023
    Share Share
    Cash crunches keep Bioasis and Celyad's feet to the fire
    Cash crunches keep Bioasis and Celyad's feet to the fire

    24 Mar 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cash-crunches-keep-bioasis-and-celyads-feet-fire-wait-better-days-continues

    Nick Paul Taylor FIERCE BIOTECH
    24 Mar 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search